ACONW — Aclarion, Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1635077 ·
Last close
$0.03
Market Cap
—
52W High
$0.03
52W Low
$0.02
ADV30
60,780
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 25,208 | 8,297 | -2,899,722 | -2,747,551 | 18,039,654 | 16,285,462 | 1,036,934 |
| Mar 2026 | 21,140 | 3,750 | -2,986,941 | -2,853,575 | 20,640,687 | 19,004,976 | 986,208 |
| Dec 2025 | 18,479 | 1,791 | -1,992,994 | -1,889,142 | 13,672,404 | 12,015,789 | 837,287 |
| Sep 2025 | 18,942 | 4,386 | -1,830,964 | -1,706,294 | 13,200,298 | 11,341,336 | 699,747 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-8,086,706
Investing CF
$-174,136
Financing CF
$11,720,647
CapEx
$-174,136
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
—
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-64,097,066
Inventory
—
Receivables
$28,172
ST Investments
—
EBIT TTM
$-9,482,099
Pretax Income TTM
$-9,196,562
Interest Exp TTM
$0
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$83,769
EBITDA
$-9,468,166
Free Cash Flow
$-5,323,035
Enterprise Value
—
Total Cash
$16,295,462
Total Debt
$0
Shares Out
—
Trailing EPS
$-6.58
Book Value
$6.91
ROE
-59.0%
ROA
-37.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 75,730 | -7,052,391 | -7,233,629 | 13,672,404 | 837,287 | 12,835,117 | -7,164,204 |
| Dec 2024 | 45,724 | -5,513,047 | -6,992,927 | 2,123,483 | 1,153,426 | 970,057 | -5,271,609 |
| Dec 2023 | 75,404 | -4,877,125 | -4,911,374 | 2,459,774 | 3,187,769 | -727,995 | -3,646,947 |
| Dec 2022 | 60,444 | -5,562,368 | -7,068,593 | 2,914,629 | 688,671 | 2,225,958 | -4,949,112 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HCA | HCA Healthcare, Inc. | $93.66B | $432.60 | — |
| NTRA | Natera, Inc. | $59.35B | $411.77 | — |
| DGX | QUEST DIAGNOSTICS INC | $26.23B | $237.62 | — |
| LH | LABCORP HOLDINGS INC. | $25.11B | $309.57 | — |
| GH | Guardant Health, Inc. | $23.80B | $177.33 | — |
News headlines (Yahoo Finance, 1h cache)
Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice
2026-07-21 11:00 · Yahoo
Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate Enrollment
2026-05-07 10:00 · Yahoo
Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site
2026-08-20 11:00 · Yahoo
Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process
2026-08-12 11:00 · Yahoo
Aclarion, Inc. (ACON) Reports Q2 Loss, Lags Revenue Estimates
2026-08-06 16:00 · Yahoo
Aclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincent, First Site in Indiana to Offer the Technology
2026-08-04 11:00 · Yahoo
Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026
2026-07-29 11:00 · Yahoo
Aclarion Announces Texas Spine Care Center as New CLARITY Site
2026-07-07 11:00 · Yahoo
Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub
2026-06-10 11:00 · Yahoo
Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform
2026-06-09 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.